Reduced Graphene Oxide/Silica Nanocomposite as Anticancer Drug Delivery Nanocarrier
-
Published:2022-10-31
Issue:4
Volume:13
Page:383
-
ISSN:2069-5837
-
Container-title:Biointerface Research in Applied Chemistry
-
language:en
-
Short-container-title:Biointerface Res Appl Chem
Abstract
This study synthesized a reduced graphene oxide-silica-based (rGO/SiO2) nanocomposite for quercetin delivery as an anticancer model drug delivery. The synthesized rGO/SiO2 nanocomposite was investigated by several characterization methods such as Fourier-transform infrared (FT-IR) spectroscopy, X-ray diffraction (XRD) analysis, and Transmission electron microscopy (TEM), and Energy-dispersive X-ray spectroscopy (EDX). The experiments result show that the rGO/SiO2 nanocomposite has been synthesized successfully and has an average particle size of 50-120 nm.
Publisher
AMG Transcend Association
Subject
Molecular Biology,Molecular Medicine,Biochemistry,Biotechnology